152 related articles for article (PubMed ID: 37331688)
1. Metabolic Disturbances in the Gut-brain Axis of a Mouse Model of MPTP-induced Parkinsonism Evaluated by Nuclear Magnetic Resonance.
Pedro Amorim Neto D; Vitor Pereira de Godoy J; Tostes K; Pelegrini Bosque B; Vieira Rodrigues P; Aparecida Rocco S; Luis Sforça M; de Castro Fonseca M
Neuroscience; 2023 Aug; 526():21-34. PubMed ID: 37331688
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
3. Gastric Enteric Glial Cells: A New Contributor to the Synucleinopathies in the MPTP-Induced Parkinsonism Mouse.
Heng Y; Li YY; Wen L; Yan JQ; Chen NH; Yuan YH
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364248
[TBL] [Abstract][Full Text] [Related]
4. Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson's disease mice by gut microbiome.
Shan J; Qu Y; Wang S; Wei Y; Chang L; Ma L; Hashimoto K
Brain Res Bull; 2021 Dec; 177():103-110. PubMed ID: 34560239
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
6. Probiotic
Pan S; Wei H; Yuan S; Kong Y; Yang H; Zhang Y; Cui X; Chen W; Liu J; Zhang Y
Front Cell Infect Microbiol; 2022; 12():1022879. PubMed ID: 36439235
[TBL] [Abstract][Full Text] [Related]
7. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).
Lei Q; Wu T; Wu J; Hu X; Guan Y; Wang Y; Yan J; Shi G
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414447
[TBL] [Abstract][Full Text] [Related]
8. Twice subacute MPTP administrations induced time-dependent dopaminergic neurodegeneration and inflammation in midbrain and ileum, as well as gut microbiota disorders in PD mice.
Xie W; Gao J; Jiang R; Liu X; Lai F; Tang Y; Xiao H; Jia Y; Bai Q
Neurotoxicology; 2020 Jan; 76():200-212. PubMed ID: 31790727
[TBL] [Abstract][Full Text] [Related]
9. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
12. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
13. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
Dong S; Sun M; He C; Cheng H
Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson's disease via the AKT signaling pathway.
Huang T; Shi H; Xu Y; Ji L
Neuroreport; 2021 Feb; 32(3):244-251. PubMed ID: 33470765
[TBL] [Abstract][Full Text] [Related]
15. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series.
Joers V; Masilamoni G; Kempf D; Weiss AR; Rotterman TM; Murray B; Yalcin-Cakmakli G; Voll RJ; Goodman MM; Howell L; Bachevalier J; Green SJ; Naqib A; Shaikh M; Engen PA; Keshavarzian A; Barnum CJ; Nye JA; Smith Y; Tansey MG
Neurobiol Dis; 2020 Oct; 144():105027. PubMed ID: 32712266
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain.
Pu Y; Chang L; Qu Y; Wang S; Zhang K; Hashimoto K
Aging (Albany NY); 2019 Sep; 11(17):6915-6929. PubMed ID: 31479418
[TBL] [Abstract][Full Text] [Related]
17. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
18. Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
Jiang Z; Wang X; Zhang H; Yin J; Zhao P; Yin Q; Wang Z
MedComm (2020); 2023 Jun; 4(3):e268. PubMed ID: 37200942
[TBL] [Abstract][Full Text] [Related]
19. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
